Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Which Sectors Lead Indices During Earnings Season examines which sectors typically drive index gains or losses, guiding allocation decisions.
26,374 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
As open enrollment kicks off in 2026, families reassess the savings from daycare with pre-tax dollars through Depende...
As companies seek sustainable productivity boosters in 2026, solo golf practice is gaining traction among executives....
As the next market cycle approaches, traders are weighing XRP against Hyperliquid, weighing price action, liquidity, ...
Airline equities tumbled in a broad market selloff after West Texas Intermediate crude surged, lifting fuel costs and...
Software shares have slid toward what some call bargain territory, but a growing argument centers on whether hidden c...
A prominent market strategist says investors should their money in gold, proposing a 10% allocation to hedge inflatio...
CME is moving to introduce Bitcoin volatility futures that track market expectations of price swings, separate from B...
In a volatile market, Hyperliquid is turning heads with its HYPE token and HIP-3 pre-IPO perps. This piece breaks dow...
Tesla just posted its strongest quarter in years, with a delivery beat powered by Model 3 and Model Y. This deep dive...
AMD signals a shift from pure CPUs to AI acceleration, blending edge and cloud compute. This article breaks down what...
A prominent hedge fund unveiled a sizable Kodiak Sciences stake, triggering chatter about what the kodiak sciences st...